Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Ophtapharm AG
483
•Ophtapharm AG•December 12, 2017

Ophtapharm AG – FDA 483, Dec 12, 2017

Record Details

An FDA inspection conducted at a finished drug product manufacturing facility in Hettlingen, Zurich, Switzerland, from December 4 to December 12, 2017, resulted in a Form 483 detailing significant observations. While the firm name is not provided, the inspection highlighted several areas of non-compliance with regulatory expectations for pharmaceutical manufacturing. Key issues included the failure to adequately establish and document the accuracy, sensitivity, and reproducibility of analytical test methods. Specifically, method transfers were incomplete, lacking essential forced degradation studies to ensure specificity for stability-indicating procedures used in product release. Additionally, the inspection identified deficiencies in maintaining separate and defined areas to prevent contamination during aseptic processing, evidenced by an uninvestigated smoke study failure in a critical aseptic filling room. Procedures for cleaning and equipment maintenance were also found to be deficient, lacking detailed instructions and efficacy evaluations for sanitization in difficult-to-reach areas. Lastly, the firm did not consistently follow its written stability testing program, omitting required examinations for product stability studies. The company is expected to implement prompt corrective actions to address these observations and ensure compliance.

Company
Ophtapharm AG
Inspection date
December 12, 2017
Office
Office of Pharmaceutical Quality Operations
Person
  • Yasamin Ameri (Compliance Officer)
View Company Profile

ID · abd01715-ac17-4651-8e5e-633204787534

Violation Codes1
21 CFR 331(c)

Full citation text and observation details available on the Dashboard.

Other documents for Ophtapharm AG
  • 483 - 2020-02-28February 28, 2020

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ophtapharm AG
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.